V-Nzyme Blend By Klaire Labs Overview & Drug Interactions
Check For Interactions With V-Nzyme Blend
Supplement: V-Nzyme Blend by Klaire Labs
This product contains
Below is a list of the 'active' ingredients listed on the supplement label for this product.
For a list of 'other ingredients', such as fillers, please see the 'Label Information' section on this page.
Enzyme Blend
Ingredient Group | Blend |
---|---|
Category | blend |
-
Aspergillus niger
Ingredient Group Aspergillus niger Category botanical
Aspergillus oryzae
Ingredient Group Aspergillus oryzae Category botanical
Rhizopus oryzae
Ingredient Group Rhizopus oryzae Category botanical
Lipase
Ingredient Group Lipase Category enzyme
Protease
Ingredient Group Proteolytic Enzymes (Proteases) Category enzyme
Acid Protease
Ingredient Group Proteolytic Enzymes (Proteases) Category enzyme
Amylase
Ingredient Group Amylase Category enzyme
Cellulase
Ingredient Group Cellulase Category enzyme
Alpha-Galactosidase
Ingredient Group Alpha Galactosidase Category enzyme
Drugs that interact with V-Nzyme Blend by Klaire Labs
Below is a list of drug interactions for each ingredient in this supplement product. Please note that a supplement product may contain more than one ingredient that has interactions.
There were no interactions found with V-Nzyme Blend. This does not mean the potential for an interaction does not exist, however. There is often a lack of studies and data surrounding traditional medicine, especially concerning drug interactions, so it is important to always consult your provider before making any changes to your medication regimen.
Label Information
Supplement Facts:
Daily Value (DV) Target Group(s): | Adults and children 4 or more years of age |
---|---|
Minimum serving Sizes: |
1 Capsule(s)
|
Maximum serving Sizes: |
1 Capsule(s)
|
Servings per container | 90 |
UPC/BARCODE | 828054005501 |
Ingredient | Amount per Serving | Group | % DV, Adults & children 4+ years |
---|---|---|---|
Enzyme Blend |
700 mg
|
Blend |
--
|
Aspergillus niger |
0 NP
|
Aspergillus niger |
|
Aspergillus oryzae |
0 NP
|
Aspergillus oryzae |
|
Rhizopus oryzae |
0 NP
|
Rhizopus oryzae |
|
Lipase |
0 NP
|
Lipase |
--
|
Protease |
0 NP
|
Proteolytic Enzymes (Proteases) |
--
|
Acid Protease |
0 NP
|
Proteolytic Enzymes (Proteases) |
--
|
Amylase |
0 NP
|
Amylase |
--
|
Cellulase |
0 NP
|
Cellulase |
--
|
Alpha-Galactosidase |
0 NP
|
Alpha Galactosidase |
--
|
Other Ingredients: |
Hydroxypropylmethylcellulose
Water
Microcrystalline Cellulose
Slippery Elm
Marshmallow
Silicon Dioxide
Magnesium Stearate
|
---|
Label Statments:
FDA Statement of Identity |
- Enzyme Supplement
|
---|---|
Brand IP Statement(s) |
- SFI
|
Precautions |
- Caution: If you are pregnant, nursing, have a medical condition, or taking prescription drugs, consult your physician before using this product.
- Keep out of reach of children.
- Do not use if shrinkwrap is broken or missing.
|
Formulation |
- Free of the following common allergens: Milk/casein, eggs, fish, shellfish, tree nuts, and peanuts. Contains no artificial colors, flavors, or preservatives.
- Produced under a strict quality management system in compliance with Good Manufacturing Practices (GMPs) and third-party quality certifications.
|
Suggested/Recommended/Usage/Directions |
- Suggested Use: 1 capsule with each meal or as directed by a healthcare professional.
|
General Statements |
- Enzyme units as defined by the Food Chemicals Codex (FCC).
|
Storage |
- Store in a cool, dry place (59 degrees F - 85 degrees F) away from direct light.
|
Brand Information
See all products by this brand
Manufactured by | |
---|---|
Name | SFI USA |
City | Reno |
State | NV |
ZipCode | 89521 |
Web Address | Klaire.com |
Return to the main supplement interaction checker page
Parts of this content are provided by the Therapeutic Research Center, LLC and the Dietary Supplement Label Database.
DISCLAIMER: Currently this does not check for drug-drug interactions. This is not an all-inclusive comprehensive list of potential interactions and is for informational purposes only. Not all interactions are known or well-reported in the scientific literature, and new interactions are continually being reported. Input is needed from a qualified healthcare provider including a pharmacist before starting any therapy. Application of clinical judgment is necessary.
© 2021 Therapeutic Research Center, LLC
Drug descriptions are provided by MedlinePlus.